ReportsandReports

ReportsandReports - The ardiovascular Market Outlook to 2015: Competitive Landscape, Global Market Analysis, Key Trends and Pipeline Analysis

The Cardiovascular Market Outlook to 2015 provides comprehensive coverage of the cardiovascular market, incorporating a disease overview and detailed epidemiological analyses of the major indications. This report makes a wide-ranging assessment of the marketed product portfolio, R&D pipeline, market share data, sales forecast and competitive landscape for the major players. Furthermore, it highlights the key market and R&D trends that may influence treatment sales; with a thorough analysis of the competitive dynamics of leading brands within each indication, in order to enable the reader to identify growing brands, key drug classes and leading players through 2015.

ReportsandReports - Innovations and Opportunities in Therapeutic Vaccines: Technology Platforms, Key Players, and Early Pipeline Candidates

Therapeutic vaccines promise a new wave of highly potent and highly specific therapeutic agents designed to work in harmony with patients’ own immune systems. Recent advances in the understanding of the human immune system and in technical capabilities have allowed vaccines to move beyond pre-emptive (prophylactic) immunization and into treatment of established diseases. In April 2010, Dendreon’s Provenge became the first ever cancer vaccine to be approved by the US Food and Drug Administration (FDA), overcoming skepticism in the investment community and paving the way for a new generation of biological therapies.

ReportsandReports - Drug Discovery Collaborations Between Academia and the Pharmaceutical Industry: Cultural Factors, Intellectual Property Considerations, Case Studies, and Future Trends

The pharmaceutical and biopharmaceutical industries are engaged in a business environment which is witnessing a dramatic escalation of R&D costs, key patent expiries, and sustained high attrition rates for new molecules in development.

ReportsandReports - Premiumization Strategies in Alcoholic Drinks: Innovating to Drive Value Through Brand and Product Enhancement

Due to rising affluence and increasing levels of health consciousness, growth in alcohol consumption has slowed in Western markets in recent years, while the sales of brands perceived as ‘premium quality’ have risen. Meanwhile in the developing world, wealthier consumers are following the same trends, whilst lower-income consumers are increasing their consumption of beer and other branded alcoholic drinks as they are increasingly able to afford them. Consumption occasions have has also changed. In markets that traditionally have a strong on-trade focus such as the UK, people are drinking more at home than in bars, restaurants and clubs – a trend that was established by the time of the 2007-2010 global financial crisis, but that was also exacerbated by its impact on incomes.

ReportsandReports - Opportunities in Non-Surgical Bio-Implants: Marketed Injectable Biomaterials, Applications, and Leading Players

Injectable bio-implants provide rapid non-surgical treatments and offer effective replacement, restoration, or modulation of function to lost, damaged, or dysregulated physiology. Market opportunities for injectable bio-implants are high in an increasingly aging population that demands fast, effective, and safe treatments for age-related conditions. Both medical and aesthetic applications for biomaterials make the market opportunities for injectable bio-implants highly attractive for drug and device manufacturers. However, biocompatibility is crucial for any implantable biomaterial to integrate into the host anatomy and prevent an immunogenic response.

ReportsandReports - The Australian Pharmaceutical Market Outlook to 2015: Policy Environment, Market Analysis, Key Trends, Growth Opportunities and Competitive Landscape

Australia is the most attractive market for pharmaceutical investment in the Asia Pacific region which is primarily due to its growing and ageing population, excellent access to medicines, and fast-recovering economy.

ReportsandReports - The Post Carbon Landscape: Alternative Pathways to a Low Carbon Landscape

Over the last 30 years more and more scientists and economists have come to understand that the world is a complex dynamic system rather than a linear Newtonian one.

ReportsandReports - Carbon Trading and the Effect of the Copenhagen Agreement: Technical Options and Economic Drivers to a Low Carbon Future

The reduction of global carbon emissions is now widely regarded as paramount if the world is to avoid major negative consequences throughout the course of the next century. Current levels of c. 380 parts per million (ppm), represent both a record high and an unprecedentedly rapid rise (by 30 ppm in just 17 years). To avoid adverse consequences – and possible catastrophe – experts believe that urgent action must be taken now to limit peak CO2 to 450 ppm.

ReportsandReports - The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine

Molecular diagnostics, essentially the analysis of DNA and RNA at the molecular level, is a fast-growing business, made possible by the growing understanding of the human genome, which has spurred growth in the diagnostic business. Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately at an earlier stage than before. The technology also is optimizing testing for sexually transmitted diseases and genetic testing. Molecular diagnostics is also addressing the need for tests that monitor the therapeutic efficacy of pharmaceuticals. In this way, it has evolved into an important business opportunity for in-vitro diagnostics makers.

ReportsandReports - The Nuclear Power Market Outlook for Developing Countries: Overview, Capacity Growth, Drivers, Resistors and Future Outlook

Nuclear power contributed about 15% to the total world electricity generation in 2009 with an installed capacity of 373GW. There are currently 436 nuclear reactors in operation in 30 countries worldwide. The US is the largest producer of nuclear power generating 31% of the total global nuclear generation followed by France, Japan and Russia. Nuclear power is an important source of power for countries such as Lithuania which generated 76.2% of its electricity through nuclear followed by France whose nuclear share in electricity generation stood at 75.2% in 2009. In addition, 16 countries generate more than 25% of their electricity through nuclear power and four countries more than 50% including Slovakia and Belgium.